Collectively, in the treatment of psoriasis vulgaris, acitretin can exert therapeutic effects via inhibiting miRNA-mediated MAPK, JAK-STAT and NF-κB signaling pathways, thereby inhibiting the proliferation of keratinocytes and inflammatory response. This evidence concerns the gene NFKB1 and psoriasis vulgaris.